Literature DB >> 30511450

Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy.

Varun Monga1, Seth M Maliske2, Hassan Kaleem3, Sarah L Mott4, Gideon K D Zamba5, Mohammed Milhem1.   

Abstract

OBJECTIVE/
BACKGROUND: Discussion of treatment goals between oncologists and patients is challenging. Patients frequently misunderstand goals of therapy. There are several methods to document goals of chemotherapy, however, and are frequently not incorporated into patient charts. METHODS/
DESIGN: Cancer patients receiving their first cycle of chemotherapy were interviewed. Patients' recall of discussions with their oncologist regarding therapy intent was assessed and compared to documentation. An adjusted McNemar's test was utilised. A one-sample proportion test was used to evaluate whether the overall observed rate of discordance was significantly different from the proposed 33% rate; a rate posited as a threshold too high in the clinical sense.
RESULTS: Two hundred and seven eligible patients were interviewed. Oncologist identified treatment goals were not documented in 24.6% of cases and had to be excluded. There was not a significant difference in the directionality of discordance present. Inter-rater agreement between patient and oncologist was found to be adequate (κ = 0.64). The overall rate of discordance (17.29%) was found to be significantly less than the proposed acceptable level of 33% (p < 0.01). Upon univariable analysis, age, gender, marital and employment status were not found to be associated with discordance.
CONCLUSIONS: Discordance between treatment goals documentation and their understanding exists, indicating continued miscommunication between the patient and oncologist.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; cancer practice; chemotherapy; rural academics; treatment goals

Mesh:

Substances:

Year:  2018        PMID: 30511450      PMCID: PMC6416062          DOI: 10.1111/ecc.12973

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  40 in total

1.  End-of-life decision making: a qualitative study of elderly individuals.

Authors:  K E Rosenfeld; N S Wenger; M Kagawa-Singer
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

2.  Cancer patient expectations of and communication with oncologists and oncology nurses: the experience of an integrated oncology and palliative care service.

Authors:  R Sapir; R Catane; B Kaufman; R Isacson; A Segal; S Wein; N I Cherny
Journal:  Support Care Cancer       Date:  2000-11       Impact factor: 3.603

Review 3.  Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.

Authors:  Rainu Kaushal; Kaveh G Shojania; David W Bates
Journal:  Arch Intern Med       Date:  2003-06-23

4.  A clinician's approach to clinical ethical reasoning.

Authors:  Lauris C Kaldjian; Robert F Weir; Thomas P Duffy
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

5.  Knowledge of treatment intent among patients with advanced cancer: a longitudinal study.

Authors:  P S Craft; C M Burns; W T Smith; D H Broom
Journal:  Eur J Cancer Care (Engl)       Date:  2005-12       Impact factor: 2.520

6.  Patients' use of the Internet for medical information.

Authors:  Joseph A Diaz; Rebecca A Griffith; James J Ng; Steven E Reinert; Peter D Friedmann; Anne W Moulton
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

7.  Goal-setting in clinical medicine.

Authors:  E H Bradley; S T Bogardus; M E Tinetti; S K Inouye
Journal:  Soc Sci Med       Date:  1999-07       Impact factor: 4.634

8.  Understanding the treatment preferences of seriously ill patients.

Authors:  Terri R Fried; Elizabeth H Bradley; Virginia R Towle; Heather Allore
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

9.  Hope and prognostic disclosure.

Authors:  Jennifer W Mack; Joanne Wolfe; E Francis Cook; Holcombe E Grier; Paul D Cleary; Jane C Weeks
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

Review 10.  Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review.

Authors:  Karen Hancock; Josephine M Clayton; Sharon M Parker; Sharon Wal der; Phyllis N Butow; Sue Carrick; David Currow; Davina Ghersi; Paul Glare; Rebecca Hagerty; Martin H N Tattersall
Journal:  Palliat Med       Date:  2007-09       Impact factor: 4.762

View more
  4 in total

1.  Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?

Authors:  Annie Wong; Alex Billett; Donna Milne
Journal:  Oncologist       Date:  2019-04-23

2.  Clinical Trials: Understanding Patient Perspectives and Beliefs About Treatment.

Authors:  Betty Ferrell; Anna Cathy Williams; Tami Borneman; Vincent Chung; Thomas J Smith
Journal:  Clin J Oncol Nurs       Date:  2019-12-01       Impact factor: 1.283

3.  Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations.

Authors:  Mahalakshmi S Rangabashyam; Shi Yan Lee; Sher Yin Tan; Stefan Mueller; Rehena Sultana; Johnatton Ho; Thakshayeni Skanthakumar; Ngian Chye Tan; Hiang Khoon Tan; Khee Chee Soo; N Gopalakrishna Iyer
Journal:  Cancer Med       Date:  2020-05-30       Impact factor: 4.452

4.  Integrating Palliative Care for Patients on Clinical Trials: Opportunities for Oncology Nurses.

Authors:  Betty Ferrell; Tami Borneman; Anna Cathy Williams; Angela Scardina; Patricia Fischer; Thomas J Smith
Journal:  Asia Pac J Oncol Nurs       Date:  2020-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.